Sino Biopharmaceutical Ltd
HKEX:1177
Wall Street
Price Targets
Price Targets Summary
Sino Biopharmaceutical Ltd
According to Wall Street analysts, the average 1-year price target for
Sino Biopharmaceutical Ltd
is 8.56 HKD
with a low forecast of 5.05 HKD and a high forecast of 12.81 HKD.
Operating Income
Forecast
Operating Income Estimate
Sino Biopharmaceutical Ltd
For the last 13 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's operating income is
17%.
The projected
CAGR
for the next 3 years is
15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Sino Biopharmaceutical Ltd's stock price target?
Price Target
8.56
HKD
According to Wall Street analysts, the average 1-year price target for
Sino Biopharmaceutical Ltd
is 8.56 HKD
with a low forecast of 5.05 HKD and a high forecast of 12.81 HKD.
What is Sino Biopharmaceutical Ltd's Revenue forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's revenue is
15%.
The projected
CAGR
for the next 3 years is
12%.
What is Sino Biopharmaceutical Ltd's Operating Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's operating income is
17%.
The projected
CAGR
for the next 3 years is
15%.
What is Sino Biopharmaceutical Ltd's Net Income forecast?
Projected CAGR
12%
For the last 13 years the
compound annual growth rate for
Sino Biopharmaceutical Ltd's net income is
19%.
The projected
CAGR
for the next 3 years is
12%.
You don't have any saved screeners yet
